PatternDNA - CANSLIM Analysis May 26th
Our recent CANSLIM scan introduced Agrium (AGU) at the expense of F5 Networks (FFIV) So what's the PatternDNA outlook for the coming five days in these eight stocks?
PatternDNA projections are derived from a pool of 18 U.S. stocks. Expected returns and win probabilities are calculated from patterns matched in stocks over the past year and performance assessed from the next open price after the pattern completes. The Average Return per Trade is based on the use of a trailing target and stop, and assumes a long position bought at the next open price (Initial stop of 10%, raised to 5% off the price reached on a 15% gain. Ultimate Profit Target of 25%).
Collectively, the outlook for the coming five days is relatively neutral. Only Baidu (BIDU) offered a projection of substance, with Research in Motion (RIMM) and Barrick Gold (ABX) behind.
PatternDNA projected a 60%+ probability of a higher close for days 1, 2 and 5 after the Pattern completes in Baidu (BIDU). However, the performance of this Pattern when a trailed stop is employed is more modest given the projected win percentage for a profitable long trade is below 60%.
Barrick Gold (ABX) offers the brightest trading opportunity when a trail stop is employed; near 70% winners with an Average Return per Trade of 4.5%. Research in Motion (RIMM) exhibits a Pattern with the highest projected Average Return per Trade of 6.0%; this from 66% winning trades and a 63% probability for a higher close next Wednesday.
While the May 3rd outlook failed to live to expectations, oversold market conditions may offer more here.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.